Buschauer A - Search Results

1

Structure-activity relationships of histamine H2-agonists, a new class of positive inotropic drugs.

Buschauer A, Baumann G. Buschauer A, et al. Agents Actions Suppl. 1991;33:231-56. doi: 10.1007/978-3-0348-7309-3_15. Agents Actions Suppl. 1991. PMID: 1828931

2

N(G)-acylated aminothiazolylpropylguanidines as potent and selective histamine H(2) receptor agonists.

Kraus A, Ghorai P, Birnkammer T, Schnell D, Elz S, Seifert R, Dove S, Bernhardt G, Buschauer A. Kraus A, et al. Among authors: buschauer a. ChemMedChem. 2009 Feb;4(2):232-40. doi: 10.1002/cmdc.200800296. ChemMedChem. 2009. PMID: 19072936

3

Point mutations in the second extracellular loop of the histamine H2 receptor do not affect the species-selective activity of guanidine-type agonists.

Preuss H, Ghorai P, Kraus A, Dove S, Buschauer A, Seifert R. Preuss H, et al. Among authors: buschauer a. Naunyn Schmiedebergs Arch Pharmacol. 2007 Dec;376(4):253-64. doi: 10.1007/s00210-007-0204-4. Epub 2007 Nov 13. Naunyn Schmiedebergs Arch Pharmacol. 2007. PMID: 17999052

4

Probing ligand-specific histamine H1- and H2-receptor conformations with NG-acylated Imidazolylpropylguanidines.

Xie SX, Ghorai P, Ye QZ, Buschauer A, Seifert R. Xie SX, et al. Among authors: buschauer a. J Pharmacol Exp Ther. 2006 Apr;317(1):139-46. doi: 10.1124/jpet.105.097923. Epub 2006 Jan 4. J Pharmacol Exp Ther. 2006. PMID: 16394198

5

The bivalent ligand approach leads to highly potent and selective acylguanidine-type histamine H₂ receptor agonists.

Birnkammer T, Spickenreither A, Brunskole I, Lopuch M, Kagermeier N, Bernhardt G, Dove S, Seifert R, Elz S, Buschauer A. Birnkammer T, et al. Among authors: buschauer a. J Med Chem. 2012 Feb 9;55(3):1147-60. doi: 10.1021/jm201128q. Epub 2012 Jan 25. J Med Chem. 2012. PMID: 22216892

6

Chiral NG-acylated hetarylpropylguanidine-type histamine H2 receptor agonists do not show significant stereoselectivity.

Ghorai P, Kraus A, Birnkammer T, Geyer R, Bernhardt G, Dove S, Seifert R, Elz S, Buschauer A. Ghorai P, et al. Among authors: buschauer a. Bioorg Med Chem Lett. 2010 May 15;20(10):3173-6. doi: 10.1016/j.bmcl.2010.03.082. Epub 2010 Mar 27. Bioorg Med Chem Lett. 2010. PMID: 20409707

7

Synthesis and structure-activity relationships of cyanoguanidine-type and structurally related histamine H4 receptor agonists.

Igel P, Geyer R, Strasser A, Dove S, Seifert R, Buschauer A. Igel P, et al. Among authors: buschauer a. J Med Chem. 2009 Oct 22;52(20):6297-313. doi: 10.1021/jm900526h. J Med Chem. 2009. PMID: 19791743

8

N(G)-acylated imidazolylpropylguanidines as potent histamine H4 receptor agonists: selectivity by variation of the N(G)-substituent.

Igel P, Schneider E, Schnell D, Elz S, Seifert R, Buschauer A. Igel P, et al. Among authors: buschauer a. J Med Chem. 2009 Apr 23;52(8):2623-7. doi: 10.1021/jm9000693. J Med Chem. 2009. PMID: 19317445

9

Acylguanidines as bioisosteres of guanidines: NG-acylated imidazolylpropylguanidines, a new class of histamine H2 receptor agonists.

Ghorai P, Kraus A, Keller M, Götte C, Igel P, Schneider E, Schnell D, Bernhardt G, Dove S, Zabel M, Elz S, Seifert R, Buschauer A. Ghorai P, et al. Among authors: buschauer a. J Med Chem. 2008 Nov 27;51(22):7193-204. doi: 10.1021/jm800841w. J Med Chem. 2008. PMID: 18950149

10

Mutations of Cys-17 and Ala-271 in the human histamine H2 receptor determine the species selectivity of guanidine-type agonists and increase constitutive activity.

Preuss H, Ghorai P, Kraus A, Dove S, Buschauer A, Seifert R. Preuss H, et al. Among authors: buschauer a. J Pharmacol Exp Ther. 2007 Jun;321(3):975-82. doi: 10.1124/jpet.107.120519. Epub 2007 Mar 8. J Pharmacol Exp Ther. 2007. PMID: 17347323

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results